Department of Clinical Sciences Lund, B11 BMC, SE-2221 84 Lund, Sweden.
J Clin Endocrinol Metab. 2010 Feb;95(2):872-8. doi: 10.1210/jc.2009-2054. Epub 2009 Dec 11.
Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are cleaved by dipeptidyl peptidase-4 (DPP-4); plasma activity of DPP-4 may be increased in obesity. The impact of this increase on incretin hormone secretion and metabolism is not known.
The aim of the study was to assess incretin hormone secretion and degradation in lean and obese nondiabetic subjects.
DESIGN, SETTINGS, AND PARTICIPANTS: We studied the ingestion of a mixed meal (560 kcal) or oral glucose (2 g/kg) in healthy lean (n = 12; body mass index, 20-25 kg/m(2)) or obese (n = 13; body mass index, 30-35 kg/m(2)) males at a University Clinical Research Unit.
We measured the area under the curve of plasma intact (i) and total (t) GIP and GLP-1 after meal ingestion and oral glucose.
Plasma DPP-4 activity was higher in the obese subjects (38.5 +/- 3.0 vs. 26.7 +/- 1.6 mmol/min . microl; P = 0.002). Although GIP secretion (AUC(tGIP)) was not reduced in obese subjects after meal ingestion or oral glucose, AUC(iGIP) was lower in obese subjects (8.5 +/- 0.6 vs. 12.7 +/- 0.9 nmol/liter x 300 min; P < 0.001) after meal ingestion. GLP-1 secretion (AUC(tGLP-1)) was reduced in obese subjects after both meal ingestion (7.3 +/- 0.9 vs. 10.0 +/- 0.6 nmol/liter x 300 min; P = 0.022) and oral glucose (6.6 +/- 0.8 vs. 9.6 +/- 1.1 nmol/liter x 180 min; P = 0.035). iGLP-1 was reduced in parallel to tGLP-1.
葡萄糖依赖性胰岛素促分泌多肽(GIP)和胰高血糖素样肽-1(GLP-1)可被二肽基肽酶-4(DPP-4)分解;肥胖患者的血浆 DPP-4 活性可能会增加。目前尚不清楚这种增加对肠降血糖素激素分泌和代谢的影响。
本研究旨在评估瘦型和肥胖非糖尿病受试者的肠降血糖素激素分泌和降解情况。
设计、地点和参与者:我们在一所大学临床研究单位研究了健康的瘦型(n = 12;体重指数 20-25 kg/m2)或肥胖型(n = 13;体重指数 30-35 kg/m2)男性进食混合餐(560 千卡)或口服葡萄糖(2 g/kg)后的血浆完整(i)和总(t)GIP 和 GLP-1 曲线下面积。
我们测量了进食和口服葡萄糖后血浆中 DPP-4 活性、GIP 和 GLP-1 的曲线下面积。
肥胖组的 DPP-4 活性更高(38.5 +/- 3.0 比 26.7 +/- 1.6 mmol/min. microl;P = 0.002)。尽管肥胖组在进食和口服葡萄糖后 GIP 分泌(AUC(tGIP)) 没有减少,但进食后 iGIP 较低(8.5 +/- 0.6 比 12.7 +/- 0.9 nmol/liter x 300 min;P < 0.001)。GLP-1 分泌(AUC(tGLP-1)) 在进食和口服葡萄糖后均减少(7.3 +/- 0.9 比 10.0 +/- 0.6 nmol/liter x 300 min;P = 0.022)(6.6 +/- 0.8 比 9.6 +/- 1.1 nmol/liter x 180 min;P = 0.035)。iGLP-1 与 tGLP-1 平行降低。
1)两种肠降血糖素激素的释放和降解在肥胖中表现出不同的变化:进食和口服葡萄糖后 GLP-1 而非 GIP 分泌减少,而 GIP 而非 GLP-1 代谢增加。2)肥胖时血浆 DPP-4 活性增加并不与普遍增加的肠降血糖素激素代谢相关。